The Global Oral Drug Delivery Market accounted for USD 119.92 Billion in 2020 and is expected to reach USD 220.32 Billion by 2028, growing at a CAGR of 7.9% from 2021 to 2028.
The Global Oral Drug Delivery Market accounted for USD 119.92 Billion in 2020 and is expected to reach USD 220.32 Billion by 2028, growing at a CAGR of 7.9% from 2021 to 2028.
Oral Drug Delivery is the most conducive and favored route of drug administration due to the factors such as least sterility constraints, patient compliance, flexibility in the design of dosage form, ease of production and cost effectiveness. The oral route of drug administration has developed over last few years, with the help of technologies and clinical trials. The market is primarily driven by increase in the prevalence of chronic diseases leading to increase in the demand for oral drug delivery systems for the treatment of such chronic diseases. To maintain the efficiency of oral drug delivery, there has been utilization of nanocarriers for oral drug delivery. The recent developments such as dome tablets, intestinal patches, polymer nano systems, dual drug tablets have been revolutionizing the field.
The COVID-19 pandemic has brought some serious medical, social and economic challenges. The supply chain eco-system has been disrupted which has led to the shortage of production. The restricted lockdowns and closed international borders have led to barriers in the transportation which has eventually led to the shortage of the raw materials. Also, the social distancing norms has led to the number of employees working in the industry for production, thus affecting the production of oral drugs.
The rising prevalence of the chronic diseases has been driving the oral drug delivery market. The growth in the research and development by various pharmaceutical companies has boosted the market. Among the drug delivery routes, oral drug delivery is most preferred one in various therapeutic areas which is also the reason to boost this market.
The growth in the biologics market and the increasing penetration of health insurance will boost the market growth. Also, increasing number of pharmaceutical companies have been driving the market. The technological developments and the new product launches in the market has also accelerated the overall drug delivery market.
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
This is due to the fact that controlled drug delivery has advantages such as the total dose is low, it has reduced dosing frequency, is better accepted by patients and is more complaint, has more uniform drug effect and has improved efficacy/safety ratio. It is the method which delivers the drug at a predetermined rate, systematically or locally, for a specified period of time.
The is mainly due to the reasons such as huge number of inpatient and outpatient visits to hospitals coming for the treatments. The high number of inpatient and outpatient visiting the hospitals increases the requirement of huge number of drugs to be administered to the patients in the hospitals. Therefore, hospitals form the major segment in the end users of oral drug delivery systems.
These centers are 45-60% less expensive than the hospitals, thus provide a significant saving to the patients. Also, the outcomes found are more improved ones and infection rates are less as compared to hospitals. The Ambulatory Surgical Centers have their services operating 24/7 and can handle any type of illness, surgery or emergency.
This is due to the factors such as new production techniques introduced to produce the syrups, available in variety of composition for the consumers and increased effectives to treat the infections and diseases. The content of the syrups provides useful vitamins, rich minerals and proteins required for the overall development of the patients. Thus, the health benefits and the wide availability is driving this segment in the Oral drug delivery market.
North America held a share of 39% in 2020. This is due to the factors such as presence of large number of pharmaceutical companies, robust pharmaceutical industry, drug delivery technology providers and rising number of collaborations between technology providers and pharmaceutical companies. Also, the increased demand for self-administration and home healthcare devices, transdermal patches and transmucosal systems for chronic diseases and increasing applications of inhalers have boosted the market in this region.
Asia-Pacific is expected to have the CAGR of 9.3% from 2021 to 2028. This is due to the factors such as saturation of the western markets and economic downfall in US and Europe. In addition, the factors such as rise in the disposable incomes, increasing penetration of the health insurance, development of healthcare infrastructure and increasing chronic diseases are boosting the overall market in this region.
Some of the key players in the Oral Drug Delivery market include AdhexPharma, Protalix, CURE Pharamceutical, Evonik, Arx LLC, Catalent Inc., INTELGENX CORP, Assembly Biosciences Inc., Aquestive Therapeutics, Emisphere Technologies, ZIM Laboratories Limited, Adare Pharmaceuticals, Merrion Pharmaceuticals Plc, Oramed Pharmaceuticals, Samyang Corporation, Chimerix Inc., Skypepharma, Amcor Limited and Unigene Laboratories Inc. amog others.
In 2020, Novo Nordisk acquired Emisphere, a drug delivery company, on a cash-free, debt free basis, for $1.35 billion. With the acquisition Novo Nordisk obtained full access to the Eligen SNAC technology platform thereby expanding its portfolio of oral biologic pipeline assets across therapy areas.
List of Figures
FIG NO. 1. Market Attractiveness Analysis, By Type
FIG NO. 2. Market Attractiveness Analysis, By End Users
FIG NO. 3. Market Attractiveness Analysis, By Product
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Oral Drug Delivery Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Type , 2020 & 2028
FIG NO. 8. Global Oral Drug Delivery Market for Controlled Release, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Oral Drug Delivery Market for Controlled Release, By Country, 2020 & 2028
FIG NO. 10. Global Oral Drug Delivery Market for Orodispersible Tablets , Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Oral Drug Delivery Market for Orodispersible Tablets , By Country, 2020 & 2028
FIG NO. 12. Market Revenue Share, By End Users , 2020 & 2028
FIG NO. 13. Global Oral Drug Delivery Market for Hospitals, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Oral Drug Delivery Market for Hospitals, By Country, 2020 & 2028
FIG NO. 15. Global Oral Drug Delivery Market for Diagnostic Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Oral Drug Delivery Market for Diagnostic Centers, By Country, 2020 & 2028
FIG NO. 17. Global Oral Drug Delivery Market for Ambulatory Surgical Centers , Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Oral Drug Delivery Market for Ambulatory Surgical Centers , By Country, 2020 & 2028
FIG NO. 19. Market Revenue Share, By Product , 2020 & 2028
FIG NO. 20. Global Oral Drug Delivery Market for tablets, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Oral Drug Delivery Market for tablets, By Country, 2020 & 2028
FIG NO. 22. Global Oral Drug Delivery Market for syrups , Revenue (USD Million) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Oral Drug Delivery Market for syrups , By Country, 2020 & 2028
FIG NO. 24. Global Oral Drug Delivery Market Revenue Share, By Region, 2020 & 2028
FIG NO. 25. North America Oral Drug Delivery Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 26. Porter’s Five Forces Analysis for Global Oral Drug Delivery Market
FIG NO. 27. PEST Analysis for Global Oral Drug Delivery Market
FIG NO. 28. Pricing Analysis for Global Oral Drug Delivery Market
FIG NO. 29. Value Chain Analysis for Global Oral Drug Delivery Market
FIG NO. 30. Company Share Analysis, 2019
FIG NO. 31. Radar Determinant Chart, 2019
FIG NO. 32. Company Strategic Developments – Heat Map Analysis
FIG NO. 33. AdhexPharma Business Segment Revenue Share, 2020 (%)
FIG NO. 34. AdhexPharma Geographical Segment Revenue Share, 2020 (%)
FIG NO. 35. Market Channels
FIG NO. 36. Marketing Channel Development Trend
FIG NO. 37. Growth in World Gross Product, 2008-2018
FIG NO. 38. Research Methodology – Detailed View
FIG NO. 39. Research Methodology
List of Tables
TABLE NO. 1. Global Oral Drug Delivery Market: Snapshot
TABLE NO. 2. Quarterly Oral Drug Delivery Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Oral Drug Delivery Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Oral Drug Delivery Market for Controlled Release, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Oral Drug Delivery Market for Orodispersible Tablets , by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Oral Drug Delivery Market for Hospitals, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Oral Drug Delivery Market for Diagnostic Centers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Oral Drug Delivery Market for Ambulatory Surgical Centers , by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Oral Drug Delivery Market for tablets, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Oral Drug Delivery Market for syrups , by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Oral Drug Delivery Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 14. North America Oral Drug Delivery Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 15. North America Oral Drug Delivery Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 16. North America Oral Drug Delivery Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 17. North America Oral Drug Delivery Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 18. U.S. Oral Drug Delivery Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 19. U.S. Oral Drug Delivery Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 20. U.S. Oral Drug Delivery Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 21. Canada Oral Drug Delivery Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 22. Canada Oral Drug Delivery Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 23. Canada Oral Drug Delivery Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 24. Mexico Oral Drug Delivery Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 25. Mexico Oral Drug Delivery Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 26. Mexico Oral Drug Delivery Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 27. Drivers for the Oral Drug Delivery Market: Impact Analysis
TABLE NO. 28. Restraints for the Oral Drug Delivery Market: Impact Analysis
TABLE NO. 29. Major Buyers of Oral Drug Delivery
TABLE NO. 30. Distributors/Traders List of Oral Drug Delivery
TABLE NO. 31. Global Oral Drug Delivery Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 32. Global Oral Drug Delivery Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
The Global Oral Drug Delivery Market was valued at USD 119.92 Billion in 2020.
The Global Oral Drug Delivery Market is expected to reach USD 220.32 Billion by 2028, growing at a CAGR of 7.9% between 2021 to 2028.
The rising prevalence of the chronic diseases has been driving the oral drug delivery market. The growth in the research and development by various pharmaceutical companies has boosted the market. Among the drug delivery routes, oral drug delivery is most preferred one in various therapeutic areas which is also the reason to boost this market. The growth in the biologics market and the increasing penetration of health insurance will boost the market growth.
North America held a share of 39% in 2020. This is due to the factors such as presence of large number of pharmaceutical companies, robust pharmaceutical industry, drug delivery technology providers and rising number of collaborations between technology providers and pharmaceutical companies. Also, the increased demand for self-administration and home healthcare devices, transdermal patches and transmucosal systems for chronic diseases and increasing applications of inhalers have boosted the market in this region.
Some of the key players in the Oral Drug Delivery market include AdhexPharma, Protalix, CURE Pharmaceutical, Evonik, Arx LLC, Catalent Inc., INTELGENX CORP, Assembly Biosciences Inc., Aquestive Therapeutics, Emisphere Technologies, ZIM Laboratories Limited, Adare Pharmaceuticals, Merrion Pharmaceuticals Plc, Oramed Pharmaceuticals, Samyang Corporation, Chimerix Inc., Skypepharma, Amcor Limited and Unigene Laboratories Inc. among others.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed